Montelukast Prescribing at HAVENSHEALTH
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,113
Total Quantity
35.3K
NHS Cost
£1.8K
vs National Avg
+62.5%
HAVENSHEALTH prescribed 1,113 items of Montelukast over the last 12 months at a cost of £1,781 to the NHS. This is 62.5% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
98
Jun 2026
83
Jun 2026
109
Jun 2026
86
Jun 2026
100
Jun 2026
87
Jun 2026
95
Jun 2026
86
Jun 2026
111
Jun 2026
84
Jun 2026
90
Jun 2026
84
Prescribing Details
| Total Items | 1,113 |
|---|---|
| Total Quantity | 35,323 |
| Total NHS Cost | £1,781 |
| Presentations | 4 different forms |
| vs National Average | +62.5% |
Montelukast Prescribing Comparison
| This practice | 1,113 items |
|---|---|
| National average per practice | 685 items |
| Difference | +62.5% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.